1 Introduction

Corneal Mosquito-borne diseases represent a significant global health challenge, affecting millions of people annually. The rapid spread of viruses such as Zika, dengue, and chikungunya has underscored the urgent need for innovative strategies to control mosquito populations and mitigate the transmission of these pathogens. Recent advancements in gene editing technologies offer promising avenues for mosquito research, potentially revolutionizing the way we approach vector control and disease prevention.

Arthropod-borne viruses (arboviruses) like Zika, dengue, and chikungunya have emerged as major public health concerns due to their rapid spread and severe health impacts. These viruses are primarily transmitted by Aedes mosquitoes, particularly Aedes aegypti and Aedes albopictus, which are prevalent in tropical and subtropical regions (Weaver et al., 2018; Jones et al., 2019). The global spread of these diseases has been facilitated by factors such as increased air travel, urbanization, and climate change, which have expanded the habitats of these mosquito vectors (Weaver et al., 2018; Liu et al., 2020). The burden of these diseases is exacerbated by the lack of effective vaccines and treatments, making vector control a critical component of disease management (Cunha et al., 2020; Bettis et al., 2022).

Genetic research has become increasingly important in the fight against mosquito-borne diseases. Traditional vector control methods, such as insecticide spraying and habitat reduction, have had limited success and face challenges such as insecticide resistance and environmental concerns (Whiteman et al., 2020). Gene editing technologies, including CRISPR-Cas9, offer novel approaches to mosquito control by enabling precise modifications to the mosquito genome. These technologies can be used to reduce mosquito populations, alter their ability to transmit pathogens, or even drive beneficial genes through mosquito populations (Bohers et al., 2020; Jones et al., 2020). For instance, gene drives have the potential to spread genes that confer resistance to pathogens throughout mosquito populations, thereby reducing disease transmission (Edgerton et al., 2020).

This study provides a comprehensive overview of advancements in gene editing technologies in mosquito research, summarizing current gene editing techniques and their applications in mosquito studies. It evaluates the effectiveness and potential risks of these technologies, identifies future research directions and potential challenges in using gene editing for mosquito control, and aims to offer guidance and reference for the development and application of gene editing technologies in combating mosquito-borne diseases.

2 Historical Perspective on Mosquito Research

2.1 Traditional genetic approaches

Historically, mosquito research has relied heavily on traditional genetic approaches, which include classical genetics and early molecular biology techniques. These methods primarily involved the use of mutagenesis and selective breeding to study gene function and inheritance patterns. For instance, early genetic studies in mosquitoes often utilized chemical mutagens or radiation to induce random mutations, followed by phenotypic screening to identify mutants with desired traits. These approaches, while foundational, were limited by their randomness and the labor-intensive nature of identifying and characterizing mutations (Adolfi and Lycett, 2018; Riabinina et al., 2022).

2.2 Early attempts at mosquito genetic manipulation

The first significant attempts at genetic manipulation in mosquitoes involved the use of transposable elements and microinjection techniques. Transposable elements, such as the piggyBac and Hermes transposons, were used to insert foreign DNA into the mosquito genome, enabling the creation of transgenic mosquitoes. These early methods were pivotal in demonstrating the feasibility of genetic manipulation in mosquitoes but were often hampered by low efficiency and technical challenges (Adolfi and Lycett, 2018; Terradas et al., 2023).

Microinjection of gene editing vectors into early-stage embryos was another early technique used for mosquito transgenesis. This method, although effective, required expensive equipment and extensive hands-on training, making it accessible only to specialized laboratories (Terradas et al., 2023). Despite these challenges, these early efforts laid the groundwork for more advanced genetic tools and techniques that would follow.

2.3 Transition to modern gene editing techniques

The advent of CRISPR/Cas9-mediated genome editing marked a significant transition in mosquito research, enabling precise and targeted genetic modifications. This technology has revolutionized the field by allowing researchers to create knock-outs, knock-ins, and other genetic modifications with unprecedented accuracy and efficiency (Macias et al., 2019; Laursen et al., 2023; Lo and Matthews, 2023). CRISPR/Cas9 has been particularly transformative in the study of mosquito biology and the development of novel vector control strategies, such as gene drives designed to spread genetic elements through mosquito populations to reduce their ability to transmit diseases (Rozen-Gagnon et al., 2020; Wang et al., 2021; Riabinina et al., 2022).

One notable advancement in modern gene editing techniques is the development of Receptor-Mediated Ovary Transduction of Cargo (ReMOT Control), which offers an alternative to traditional embryo injection methods. ReMOT Control simplifies the process by allowing gene editing vectors to be delivered to adult mosquito ovaries, thus bypassing the need for embryo injections. This technique has been successfully applied to various mosquito species, including Aedes aegypti and Anopheles stephensi, and has expanded the accessibility of CRISPR/Cas9-based gene editing to a broader range of laboratories (Macias et al., 2019; Terradas et al., 2023).

Additionally, the use of distinguishably marked knock-in pairs (DMKPs) has facilitated the study of genes essential for reproduction or survival in mosquitoes. DMKPs enable the maintenance and study of mutations that cannot be sustained in a homozygous state, such as recessive lethal and sterile mutations. This approach has proven effective in both Drosophila melanogaster and Aedes aegypti, demonstrating its potential for broader application in mosquito research (Laursen et al., 2023).

3 CRISPR-Cas9 in Mosquito Research

3.1 Mechanism of CRISPR-Cas9

The CRISPR-Cas9 system is a revolutionary tool for genome editing, characterized by its high efficiency, ease of use, and precision. The mechanism involves two key components: the Cas9 protein, which acts as a molecular scissor, and a guide RNA (gRNA) that directs Cas9 to a specific location in the genome. The gRNA binds to a complementary DNA sequence, and the Cas9 protein induces a double-strand break at this site. The cell's natural repair mechanisms then attempt to fix the break, often leading to insertions or deletions that can disrupt gene function (Gupta et al., 2019; Manghwar et al., 2019).

3.2 Applications in mosquito gene editing

CRISPR-Cas9 has been widely adopted in mosquito research for various applications, including gene knockout, gene knock-in, and the development of gene drives. These applications aim to understand mosquito biology better and develop novel vector control strategies. For instance, CRISPR-Cas9 has been used to disrupt genes involved in mosquito olfaction, which is crucial for host-seeking behavior, thereby reducing their ability to transmit diseases (Figure 1) (Macias et al., 2019; Wang and Doudna, 2023). Additionally, CRISPR-based gene drives have been designed to spread genetic modifications rapidly through mosquito populations, offering a promising approach to controlling vector-borne diseases (Lo and Matthews, 2023).

3.3 Success stories and case studies

Several successful case studies highlight the potential of CRISPR-Cas9 in mosquito research. One notable example is the use of CRISPR-Cas9 to create targeted mutations in the malaria vector Anopheles stephensi using the ReMOT Control technique, which bypasses the need for embryo injections and makes the technology accessible to more laboratories (Macias et al., 2019). Another success story involves the precise integration of a marker gene into the odorant receptor co-receptor (Orco) in Anopheles sinensis, significantly impairing the mosquito's ability to locate and discriminate human hosts (Wang et al., 2022). These studies demonstrate the versatility and effectiveness of CRISPR-Cas9 in advancing mosquito research and vector control.

3.4 Limitations and challenges

Despite its advantages, the CRISPR-Cas9 system faces several limitations and challenges. One major concern is off-target effects, where unintended genomic sites are edited, potentially leading to adverse outcomes (Gupta et al., 2019; Guo et al., 2023). Efforts to mitigate these effects include the development of high-fidelity Cas9 variants and paired nickases that reduce off-target activity (Gupta et al., 2019). Another challenge is the efficient delivery of CRISPR components into mosquito cells. Traditional methods like embryo injections are technically demanding and inefficient, prompting the exploration of alternative delivery systems such as non-viral vectors and ReMOT Control (Li et al., 2018; Macias et al., 2019). Additionally, the ethical and ecological implications of releasing genetically modified mosquitoes into the environment require careful consideration and regulatory oversight (Wang and Doudna, 2023).

4 Other Emerging Gene Editing Technologies

4.1 TALENs (transcription activator-like effector nucleases)

Transcription Activator-Like Effector Nucleases (TALENs) are engineered nucleases that can create double-strand breaks (DSBs) at specific locations in the genome. TALENs are composed of a DNA-binding domain derived from transcription activator-like effectors (TALEs) and a FokI nuclease domain. The DNA-binding domain can be customized to target specific DNA sequences, making TALENs highly versatile for genome editing applications. TALENs have been successfully used in various fields, including the creation of animal models and gene therapy development (Bak et al., 2018; Li et al., 2020; Castro et al., 2021).

4.2 ZFNs (zinc finger nucleases)

Zinc Finger Nucleases (ZFNs) are another class of engineered nucleases that facilitate targeted genome editing by creating DSBs at specific genomic locations. ZFNs consist of a DNA-binding domain composed of zinc finger proteins and a FokI nuclease domain. The zinc finger proteins can be engineered to recognize specific DNA sequences, allowing precise targeting. ZFNs have been utilized in both basic research and clinical applications, including the development of disease models and potential therapies for genetic disorders (Khan et al., 2019; Li et al., 2020; Castro et al., 2021).

4.3 Base editing and prime editing

Base editing and prime editing are newer gene editing technologies that allow for precise modifications at the single-nucleotide level without creating DSBs. Base editing uses a modified CRISPR-Cas9 system to convert one DNA base pair into another, enabling targeted point mutations. Prime editing, on the other hand, uses a reverse transcriptase enzyme fused to a Cas9 nickase to directly write new genetic information into a target DNA site. These technologies offer higher precision and reduced off-target effects compared to traditional genome editing methods (Naeem et al., 2020).

4.4 Comparative advantages and disadvantages

Each gene editing technology has its own set of advantages and disadvantages, making them suitable for different applications:

TALENs: TALENs offer high specificity and can target a wide range of DNA sequences. However, they are relatively complex to design and produce, which can limit their widespread use (Li et al., 2020; Castro et al., 2021).

ZFNs: ZFNs are highly specific and have been successfully used in clinical trials. However, they are also complex to design and can have off-target effects, which may pose safety concerns (Khan et al., 2019; Li et al., 2020).

Base Editing and Prime Editing: These newer technologies provide high precision and reduced off-target effects, making them highly promising for therapeutic applications. However, they are still in the early stages of development, and more research is needed to fully understand their potential and limitations (Naeem et al., 2020).

5 Gene Drive Systems in Mosquito Population Control

5.1 Mechanism of gene drives

Gene drives are genetic systems that increase the likelihood of a particular gene being passed on to the next generation, thereby enabling the rapid spread of specific traits through a population. The most commonly used gene drive systems in mosquito research are based on CRISPR/Cas9 technology. These systems can be designed to either suppress mosquito populations by reducing their reproductive capacity or modify populations to make them less capable of transmitting diseases (James et al., 2018; Adolfi et al., 2020; Nolan, 2020). For instance, CRISPR-based gene drives can target genes essential for female fertility, leading to population suppression, or introduce genes that render mosquitoes resistant to pathogens like the malaria parasite (Figure 2) (Carballar-Lejarazú et al., 2020; Hammond et al., 2021).

Carballar-Lejarazú et al. (2020) presents a detailed visual representation of a gene-drive experiment targeting the Agcd gene in Anopheles gambiae mosquitoes. It highlights the pCO37 plasmid design, which integrates into the mosquito genome through homology-directed repair (HDR), leading to the disruption of the Agcd gene. The resulting phenotypes show the expression of a fluorescent marker (CFP) in larvae, and a notable "red eye" mutation in both pupae and adult mosquitoes, indicating successful gene editing. The comparison between wild-type and genetically modified mosquitoes is shown across developmental stages, emphasizing the visual impact of the mutation. This research is significant in advancing mosquito gene-drive technology, potentially for vector control, by demonstrating effective genetic manipulation through CRISPR-Cas9. This system demonstrates gene-drive efficiency in creating heritable mutations, contributing to mosquito population control research.

5.2 Recent advances in gene drive technologies

Recent advancements in gene drive technologies have focused on improving efficiency, specificity, and safety. For example, the development of split-gene drives in Aedes aegypti has shown high cleavage and transmission rates, suggesting potential for safe and reversible field applications (Li et al., 2019). Additionally, threshold-dependent gene drives, which require a high frequency of released individuals to spread, offer a more controlled and localized approach to gene drive deployment (Leftwich et al., 2018). Another significant advancement is the creation of gene-drive rescue systems that mitigate fitness costs associated with gene drive integration, ensuring more stable and effective population modification (Adolfi et al., 2020).

5.3 Ethical considerations and public perception

The deployment of gene drive technologies raises several ethical concerns and public perception issues. Key ethical considerations include the potential for unintended ecological consequences, the need for informed consent from affected communities, and the long-term impacts on biodiversity. Public perception studies, such as those conducted with California residents, reveal pragmatic concerns about cost, control, and trust in institutions rather than outright rejection of gene drive technologies (Schairer et al., 2022). Engaging with communities early in the development process is crucial to align scientific goals with public priorities and ensure ethical deployment (James et al., 2018).

5.4 Case studies and field trials

Several case studies and field trials have demonstrated the potential and challenges of gene drive systems in mosquito population control. For instance, small cage trials with Anopheles stephensi showed that single releases of gene-drive males could achieve efficient population modification within 5-11 generations (Adolfi et al., 2020). Similarly, large cage trials with Anopheles gambiae demonstrated the suppressive activity of gene drives, achieving full population suppression within a year without selecting for resistance (Hammond et al., 2021). These trials highlight the importance of stepwise testing, from confined laboratory settings to more ecologically relevant environments, to ensure the safety and efficacy of gene drive technologies before field deployment (James et al., 2018; Nolan, 2020).

6 Advances in Delivery Methods for Gene Editing

6.1 Microinjection techniques

Microinjection remains a cornerstone technique for delivering gene editing tools directly into mosquito embryos. This method, while precise, is technically challenging and labor-intensive, often requiring specialized equipment and expertise. Recent advancements have focused on improving the efficiency and applicability of microinjection. For instance, the Receptor-Mediated Ovary Transduction of Cargo (ReMOT Control) technique has been developed to deliver Cas9 ribonucleoprotein (RNP) complexes directly into the ovaries of adult female mosquitoes, bypassing the need for embryonic microinjection. This method has shown promising results in generating heritable gene edits with high efficiency across multiple mosquito species (Chaverra-Rodriguez et al., 2018; Macias et al., 2019).

6.2 Electroporation and viral vectors

Electroporation has emerged as a viable alternative to microinjection, particularly for non-embryonic stages. This technique uses electric pulses to create transient pores in cell membranes, allowing the uptake of nucleic acids. A study demonstrated the effectiveness of electroporation-mediated delivery in Anopheles sinensis, achieving significant gene silencing and stable transgenesis in targeted body parts (Che et al., 2020). Additionally, viral vectors such as baculovirus have been explored for their ability to transduce mosquito cells efficiently. Baculovirus vectors can deliver genes without viral propagation, resulting in high-level gene expression with minimal negative effects on cell viability (Naik et al., 2018).

6.3 Nanotechnology-based delivery systems

Nanotechnology offers innovative solutions for gene delivery, leveraging the small size and unique properties of nanoparticles to enhance transfection efficiency and reduce cellular perturbation. Nanostructure electro-injection (NEI) platforms, for example, utilize localized electric fields to facilitate the entry of DNA into cells, achieving higher transfection efficiency and lower cell stress compared to traditional methods (Tay and Melosh, 2019). Polyester-based nanoparticles, such as those made from poly (lactic-co-glycolic acid) (PLGA), have also been employed to deliver CRISPR/Cas9 components, offering advantages in terms of safety, targeting specificity, and scalability (Piperno et al., 2021).

6.4 Innovations in delivery efficiency

The quest for more efficient and safer delivery methods has led to the exploration of non-viral delivery platforms. These platforms aim to overcome the limitations of viral vectors, such as immunogenicity and packaging constraints. Non-viral methods, including the use of synthetic vectors like lipid nanoparticles, have shown promise in delivering CRISPR/Cas9 components with minimal off-target effects and immune activation (Wilbie et al., 2019). Additionally, advancements in physical transfection methods, such as micro and nanotechnology-based approaches, are being developed to improve the performance and applicability of gene editing tools (Fajrial et al., 2020).

7 Impacts on Mosquito Behavior and Ecology

7.1 Genetic modifications and mosquito fitness

Genetic modifications in mosquitoes, particularly through CRISPR/Cas9-based gene editing, have shown significant impacts on mosquito fitness. For instance, the introduction of the kdr mutation L1014F in Anopheles gambiae increased resistance to pyrethroids and DDT but also resulted in fitness disadvantages such as increased larval mortality and reduced adult longevity and fecundity (Grigoraki et al., 2021). Similarly, gene-drive systems targeting the kynurenine hydroxylase gene in Anopheles stephensi have been developed to relieve the fitness load in females, ensuring efficient population modification (Adolfi et al., 2020). These modifications are crucial for the success of gene-drive technologies, as they must balance the benefits of pathogen resistance with the potential fitness costs to the mosquito population.

Grigoraki et al. (2021) illustrates the effects of the L1014F mutation on the development, fecundity, fertility, and survival of Kisumu mosquito strains. It highlights that mosquitoes carrying the L1014F mutation (Kisumu-F/F) experience notable developmental delays, with a lower percentage of larvae reaching the pupae stage compared to wild-type mosquitoes (Kisumu-L/L). The fecundity of Kisumu-F/F females is also reduced, with fewer females laying eggs after a blood meal. However, there is no significant difference in the number of eggs laid or larvae hatched between the two strains. Additionally, Kisumu-F/F females have a shorter lifespan than the wild-type strain. Overall, the mutation introduces fitness costs, affecting multiple life history traits that could influence the success of genetically modified mosquito populations in control strategies.

7.2 Ecological risks and benefits

The deployment of genetically engineered mosquitoes (GEMs) carries both ecological risks and benefits. One of the primary benefits is the potential to reduce the transmission of vector-borne diseases such as malaria and dengue by modifying mosquito populations to be refractory to pathogens (Lanzaro et al., 2021; Wang et al., 2021). However, the ecological risks include the possibility of unintended consequences on non-target species and ecosystems. For example, the release of GEMs into the wild requires careful site selection to minimize risks and ensure ecological containment (Lanzaro et al., 2021). Additionally, the potential for gene-drive resistance and the ecological impact of reduced mosquito populations must be considered (Hammond et al., 2021). The balance between these risks and benefits is critical for the successful implementation of genetic control technologies.

7.3 Behavioral changes in gene-edited mosquitoes

Gene editing can also lead to behavioral changes in mosquitoes. For example, CRISPR-based gene drives targeting the doublesex gene in Anopheles gambiae have been shown to suppress reproductive capabilities, leading to population suppression (Hammond et al., 2021). These behavioral changes are essential for the effectiveness of gene-drive technologies, as they directly impact the ability of mosquitoes to reproduce and transmit diseases. Furthermore, the introduction of pathogen-blocking genes can alter mosquito feeding behaviors, potentially reducing their interaction with humans and other hosts (Wang et al., 2021). Understanding these behavioral changes is crucial for predicting the long-term impacts of gene-edited mosquitoes on disease transmission and ecosystem dynamics.

8 Regulatory and Ethical Considerations

8.1 Current regulatory frameworks

The regulatory landscape for gene editing in mosquitoes is complex and varies significantly across different regions. Current frameworks often struggle to keep pace with the rapid advancements in gene editing technologies such as CRISPR/Cas9. For instance, the development of gene-drive systems, which can spread genetic modifications rapidly through mosquito populations, has raised significant regulatory challenges. These systems, like the one developed for population modification in Anopheles stephensi, demonstrate the need for robust regulatory oversight to manage potential ecological impacts and ensure biosafety (Adolfi et al., 2020). Additionally, the use of CRISPR/Cas9 for gene editing in mosquito cell lines and symbiotic bacteria further complicates the regulatory landscape, as these applications can have far-reaching implications for both vector control and public health (Hegde et al., 2019; Rozen-Gagnon et al., 2020).

8.2 Ethical debates on gene editing in mosquitoes

The ethical considerations surrounding gene editing in mosquitoes are multifaceted and contentious. One major ethical debate centers on the potential ecological consequences of releasing genetically modified mosquitoes into the wild. The ability of gene drives to potentially eradicate entire mosquito species raises questions about biodiversity and the unforeseen impacts on ecosystems (Leftwich et al., 2018). Moreover, the use of gene editing technologies in mosquitoes, such as the ReMOT Control technique for heritable gene editing, has sparked discussions about the moral implications of manipulating the genetics of living organisms for human benefit (Chaverra-Rodriguez et al., 2018; Macias et al., 2019). Ethical concerns also extend to the potential for unintended consequences, such as the development of resistance in mosquito populations or the transfer of modified genes to non-target species (Cisnetto and Barlow, 2020).

8.3 Future directions in policy and regulation

Future policy and regulatory frameworks must evolve to address the unique challenges posed by gene editing technologies in mosquitoes. One promising direction is the development of threshold-dependent gene drives, which require a high frequency of release before the modified genes can spread, thereby offering a more controlled and reversible approach to genetic modification (Leftwich et al., 2018). Additionally, there is a need for international collaboration to establish standardized guidelines and risk assessment protocols that can be universally applied. This includes the creation of feedback loops in the regulatory process to incorporate new scientific evidence and public opinion, ensuring that policies remain adaptive and responsive to emerging technologies (Cisnetto and Barlow, 2020). Furthermore, advancements in gene editing techniques, such as the use of insect promoters for spatial-temporal gene expression, highlight the importance of ongoing research to refine and improve the safety and efficacy of these technologies (Bottino-Rojas and James, 2022).

9 Future Perspectives and Challenges

9.1 Potential for eradication of mosquito-borne diseases

The potential for eradicating mosquito-borne diseases through gene editing technologies is promising. Recent advancements in gene drives, particularly those that are threshold-dependent, offer the possibility of modifying entire mosquito populations to reduce their ability to transmit diseases such as malaria, dengue, and chikungunya (Leftwich et al., 2018). These gene drives can be designed to spread anti-pathogen genes throughout mosquito populations, potentially leading to the global eradication of these diseases (Li et al., 2018). However, the implementation of these technologies must be carefully managed to address concerns about ecological impacts and the potential for resistance development (Caragata et al., 2020; Wang et al., 2021).

9.2 Technological innovations on the horizon

Several technological innovations are on the horizon that could further enhance the effectiveness of gene editing in mosquito research. The integration of CRISPR technology with digital twin models is one such innovation, which could improve experimental outcomes and provide more precise control over gene editing processes (Luo et al., 2023). Additionally, the development of split-gene drives in Aedes aegypti has shown high efficiency in spreading anti-pathogen genes, offering a safe and reversible method for controlling mosquito populations (Li et al., 2018). Advances in CRISPR tools and site-directed transgenesis in Culex mosquitoes also highlight the potential for expanding gene drive applications to other mosquito species (Feng et al., 2021).

9.3 Addressing global challenges and collaboration needs

Addressing global challenges in mosquito-borne disease control requires international collaboration and public engagement. Studies have shown that public perception and acceptance of gene drive technologies are crucial for their successful implementation (Schairer et al., 2022). Engaging with communities and stakeholders early in the development process can help align scientific goals with public concerns and priorities. Furthermore, global collaboration is essential to ensure that gene editing technologies are developed and deployed in a manner that is safe, ethical, and effective. This includes sharing knowledge, resources, and best practices across borders to tackle the complex and widespread issue of mosquito-borne diseases (Sanchez et al., 2019).

In conclusion, while significant progress has been made in gene editing technologies for mosquito research, future efforts must focus on refining these technologies, addressing ecological and ethical concerns, and fostering global collaboration to achieve the ultimate goal of eradicating mosquito-borne diseases.

10 Conclusion

Recent advancements in gene editing technologies have significantly impacted mosquito research, particularly in the control of mosquito-borne diseases. The introduction and development of CRISPR/Cas9 technology have revolutionized the field, enabling precise genetic modifications that were previously unattainable. Techniques such as Receptor-Mediated Ovary Transduction of Cargo (ReMOT Control) have simplified the process of gene editing in mosquitoes, making it accessible to more laboratories by eliminating the need for complex embryo injections. Additionally, gene-drive systems have shown promise in both population suppression and modification, offering new strategies for reducing the transmission of diseases like malaria and dengue. The use of RNA interference (RNAi) for mosquito control has also progressed, with oral RNAi-based pesticides emerging as a potential tool to combat insecticide resistance.

The advancements in gene editing technologies hold significant implications for public health and mosquito control. By enabling the development of genetically modified mosquitoes that are less capable of transmitting pathogens, these technologies offer a sustainable and potentially more effective alternative to traditional insecticides and environmental control methods. The ability to create heritable genetic modifications means that once released, these modified mosquitoes can propagate the desired traits through wild populations, potentially leading to long-term reductions in disease transmission. Moreover, the scalability and deployability of these genetic solutions make them suitable for large-scale implementation, which is crucial for addressing the global burden of mosquito-borne diseases.

While the advancements in gene editing technologies for mosquito research are promising, several challenges and areas for future research remain. The potential ecological impacts of releasing genetically modified mosquitoes into the environment need to be thoroughly assessed to ensure that these interventions do not inadvertently harm ecosystems. Additionally, the development of more efficient and species-specific gene editing tools will be essential for expanding the applicability of these technologies to a broader range of mosquito species. Future research should also focus on integrating these genetic approaches with other control strategies, such as the use of Wolbachia bacteria, to enhance their effectiveness and sustainability. As the field continues to evolve, interdisciplinary collaborations and advancements in related technologies, such as artificial intelligence, will likely play a crucial role in overcoming current limitations and achieving the goal of eradicating mosquito-borne diseases.

Acknowledgments

The authors are deeply grateful to Professor Zhang Wenfei from the School of Life Sciences at Hainan Normal University for carefully reading this manuscript and providing highly valuable suggestions for revision.

Conflict of Interest Disclosure

The authors affirm that this research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.

References

Adolfi A., and Lycett G., 2018, Opening the toolkit for genetic analysis and control of Anopheles mosquito vectors, Current Opinion in Insect Science, 30: 8-18.

https://doi.org/10.1016/j.cois.2018.07.014

Adolfi A., Gantz V., Jasinskiene N., Lee H., Hwang K., Terradas G., Bulger E., Ramaiah A., Bennett J., Emerson J., Marshall J., Bier E., and James A., 2020, Efficient population modification gene-drive rescue system in the malaria mosquito Anopheles stephensi, Nature Communications, 11: 5553.

https://doi.org/10.1038/s41467-020-19426-0

Bak R., Gomez-Ospina N., and Porteus M., 2018, Gene editing on center stage, Trends in Genetics: TIG, 34(8): 600-611.

https://doi.org/10.1016/j.tig.2018.05.004

Bettis A., Jackson M., Yoon I., Breugelmans J., Goios A., Gubler D., and Powers A., 2022, The global epidemiology of chikungunya from 1999 to 2020: A systematic literature review to inform the development and introduction of vaccines, PLoS Neglected Tropical Diseases, 16(1): e0010069.

https://doi.org/10.1371/journal.pntd.0010069

Bohers C., Mousson L., Madec Y., Vazeille M., Rhim A., M'ghirbi Y., Bouattour A., and Failloux A., 2020, The recently introduced Aedes albopictus in Tunisia has the potential to transmit chikungunya, dengue and Zika viruses, PLoS Neglected Tropical Diseases, 14(10): e0008475.

https://doi.org/10.1371/journal.pntd.0008475

Bottino-Rojas V., and James A., 2022, Use of insect promoters in genetic engineering to control mosquito-borne diseases, Biomolecules, 13(1): 16.

https://doi.org/10.3390/biom13010016

Caragata E., Dong S., Dong Y., Simões M., Tikhe C., and Dimopoulos G., 2020, Prospects and pitfalls: next-generation tools to control mosquito-transmitted disease, Annual Review of Microbiology, 74: 455-475.

https://doi.org/10.1146/annurev-micro-011320-025557

Carballar-Lejarazú R., Ogaugwu C., Tushar T., Kelsey A., Pham T., Murphy J., Schmidt H., Lee Y., Lanzaro G., and James A., 2020, Next-generation gene drive for population modification of the malaria vector mosquito, Anopheles gambiae, Proceedings of the National Academy of Sciences of the United States of America, 117: 22805-22814.

https://doi.org/10.1073/pnas.2010214117

Castro N., Bjelic J., Malhotra G., Huang C., and Alsaffar S., 2021, Comparison of the feasibility, efficiency, and safety of genome editing technologies, International Journal of Molecular Sciences, 22.

https://doi.org/10.3390/ijms221910355

Chaverra-Rodriguez D., Macias V., Hughes G., Pujhari S., Suzuki Y., Peterson D., Kim D., McKeand S., and Rasgon J., 2018, Targeted delivery of CRISPR-Cas9 ribonucleoprotein into arthropod ovaries for heritable germline gene editing, Nature Communications, 9: 3008.

https://doi.org/10.1038/s41467-018-05425-9

Che L., He Z., Liu Y., Yan Z., Han B., Chen X., He X., Zhang J., Chen B., and Qiao L., 2020, Electroporation-mediated nucleic acid delivery during non-embryonic stages for gene-function analysis in Anopheles sinensis, Insect Biochemistry and Molecular Biology, 128: 103500.

https://doi.org/10.1016/j.ibmb.2020.103500

Cisnetto V., and Barlow J., 2020, The development of complex and controversial innovations, Genetically Modified Mosquitoes for Malaria Eradication, Research Policy, 49(3): 103917.

https://doi.org/10.1016/j.respol.2019.103917

Cunha M., Costa P., Corrêa I., Souza M., Calil P., Silva G., Costa S., Fonseca V., and Costa L., 2020, Chikungunya virus: an emergent arbovirus to the south American continent and a continuous threat to the world, Frontiers in Microbiology, 11: 1297.

https://doi.org/10.3389/fmicb.2020.01297

Edgerton S., Thongsripong P., Wang C., Montaya M., Balmaseda A., Harris E., and Bennett S., 2020, Evolution and epidemiologic dynamics of dengue virus in Nicaragua during the emergence of chikungunya and Zika viruses, Infection, Genetics and Evolution : Journal Of Molecular Epidemiology And Evolutionary Genetics In Infectious Diseases, 92: 104680.

https://doi.org/10.1016/j.meegid.2020.104680

Fajrial A., He Q., Wirusanti N., Slansky J., and Ding X., 2020, A review of emerging physical transfection methods for CRISPR/Cas9-mediated gene editing, Theranostics, 10: 5532-5549.

https://doi.org/10.7150/thno.43465

Feng X., Amo V., Mameli E., Lee M., Bishop A., Perrimon N., and Gantz V., 2021, Optimized CRISPR tools and site-directed transgenesis towards gene drive development in Culex quinquefasciatus mosquitoes, Nature Communications, 12: 2960.

https://doi.org/10.1038/s41467-021-23239-0

Grigoraki L., Cowlishaw R., Nolan T., Donnelly M., Lycett G., and Ranson H., 2021, CRISPR/Cas9 modified An. gambiae carrying kdr mutation L1014F functionally validate its contribution in insecticide resistance and combined effect with metabolic enzymes, PLoS Genetics, 17(7): e1009556.

https://doi.org/10.1371/journal.pgen.1009556

Guo C., Ma X., Gao F., and Guo Y., 2023, Off-target effects in CRISPR/Cas9 gene editing, Frontiers in Bioengineering and Biotechnology, 11: 1143157.

https://doi.org/10.3389/fbioe.2023.1143157

Gupta D., Bhattacharjee O., Mandal D., Sen M., Dey D., Dasgupta A., Kazi T., Gupta R., Sinharoy S., Acharya K., Chattopadhyay D., Ravichandiran V., Roy S., and Ghosh, D., 2019, CRISPR-Cas9 system: A new-fangled dawn in gene editing, Life Sciences, 232(1): 116636.

https://doi.org/10.1016/j.lfs.2019.116636

Hammond A., Pollegioni P., Persampieri T., North A., Minuz R., Trusso A., Bucci A., Kyrou K., Morianou I., Simoni A., Nolan T., Müller R., and Crisanti A., 2021, Gene-drive suppression of mosquito populations in large cages as a bridge between lab and field, Nature Communications, 12: 4589.

https://doi.org/10.1038/s41467-021-24790-6

Hegde S., Nilyanimit P., Kozlova E., Anderson E., Narra H., Sahni S., Heinz E., and Hughes G., 2019, CRISPR/Cas9-mediated gene deletion of the ompA gene in symbiotic Cedecea neteri impairs biofilm formation and reduces gut colonization of Aedes aegypti mosquitoes, PLoS Neglected Tropical Diseases, 13(12): e0007883.

https://doi.org/10.1371/journal.pntd.0007883

James S., Collins F., Welkhoff P., Emerson C., Godfray H., Gottlieb M., Greenwood B., Lindsay S., Mbogo C., Okumu F., Okumu F., Okumu F., Quemada H., Savadogo M., Singh J., Tountas K., and Touré Y., 2018, Pathway to deployment of gene drive mosquitoes as a potential biocontrol tool for elimination of malaria in Sub-Saharan Africa: recommendations of a scientific working group, The American Journal of Tropical Medicine and Hygiene, 98: 1-49.

https://doi.org/10.4269/ajtmh.18-0083

Jones R., Kulkarni M., Davidson T., and Talbot B., 2019, Arbovirus vectors of epidemiological concern in the Americas: a scoping review of entomological studies on Zika, dengue and chikungunya virus vectors, PLoS ONE, 15(2): e022075.

https://doi.org/10.1371/journal.pone.0220753

Khan S., 2019, Genome-editing technologies: concept, pros, and cons of various genome-editing techniques and bioethical concerns for clinical application. molecular therapy, Nucleic Acids, 16: 326-334.

https://doi.org/10.1016/j.omtn.2019.02.027

Lanzaro G., Campos M., Crepeau M., Cornel A., Estrada A., Gripkey H., Haddad Z., Kormos A., Palomares S., and Sharpee W., 2021, Selection of sites for field trials of genetically engineered mosquitoes with gene drive, Evolutionary Applications, 14: 2147-2161.

https://doi.org/10.1111/eva.13283

Laursen W., Busby R., Sarkissian T., Chang E., and Garrity P., 2023, DMKPs provide a generalizable strategy for studying genes required for reproduction or viability in non-traditional model organisms, Genetics, 224(2): iyad057.

https://doi.org/10.1093/genetics/iyad057

Leftwich P., Edgington M., Harvey‐Samuel T., Paladino L., Norman V., and Alphey L., 2018, Recent advances in threshold-dependent gene drives for mosquitoes, Biochemical Society Transactions, 46: 1203-1212.

https://doi.org/10.1042/BST20180076

Li H., Yang Y., Hong W., Huang M., Wu M., and Zhao X., 2020, Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects, Signal Transduction and Targeted Therapy, 5: 1.

https://doi.org/10.1038/s41392-019-0089-y

Li L., Hu S., and Chen X., 2018, Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities, Biomaterials, 171: 207-218.

https://doi.org/10.1016/j.biomaterials.2018.04.031

Li M., Yang T., Kandul N., Bui M., Gamez S., Raban R., Bennett J.C.H., Lanzaro G., Schmidt H., Lee Y., Marshall J., and Akbari O., 2019, Development of a confinable gene drive system in the human disease vector Aedes aegypti, eLife, 9: 1-40.

https://doi.org/10.1101/645440

Liu Y., Lillepold K., Semenza J., Tozan Y., Quam M., and Rocklöv J., 2020, Reviewing estimates of the basic reproduction number for dengue, Zika and chikungunya across global climate zones, Environmental Research, 182: 109114.

https://doi.org/10.1016/j.envres.2020.109114

Lo I., and Matthews B., 2023, Design and validation of guide RNAs for CRISPR-Cas9 genome editing in mosquitoes, Cold Spring Harbor protocols, 10.

https://doi.org/10.1101/pdb.top107688

Luo L., Wang J., and Wang L., 2023, Application and prospects of gene editing in mosquito-borne disease control, Theoretical and Natural Science, 8: 40-45.

https://doi.org/10.54254/2753-8818/8/20240357

Macias V., McKeand S., Chaverra-Rodriguez D., Hughes G., Fazekas A., Pujhari S., Jasinskiene N., James A., and Rasgon J., 2019, Cas9-mediated gene-editing in the malaria mosquito anopheles stephensi by ReMOT control, G3: Genes|Genomes|Genetics, 10: 1353-1360.

https://doi.org/10.1534/g3.120.401133

Manghwar H., Lindsey K., Zhang X., and Jin S., 2019, CRISPR/Cas system: recent advances and future prospects for genome editing, Trends in Plant Science, 24(12): 1102-1125.

https://doi.org/10.1016/j.tplants.2019.09.006

Naeem M., Majeed S., Hoque M., and Ahmad I., 2020, Latest developed strategies to minimize the off-target effects in CRISPR-Cas-mediated genome editing, Cells, 9(7): 1608.

https://doi.org/10.3390/cells9071608

Naik N., Lo Y., Wu T., Lin C., Kuo S., and Chao Y., 2018, Baculovirus as an efficient vector for gene delivery into mosquitoes, Scientific Reports, 8: 17778.

https://doi.org/10.1038/s41598-018-35463-8

Nolan T., 2020, Control of malaria-transmitting mosquitoes using gene drives, Philosophical Transactions of the Royal Society B, 376(1818): 20190803.

https://doi.org/10.1098/rstb.2019.0803

Piperno A., Sciortino M., Giusto E., Montesi M., Panseri S., and Scala A., 2021, Recent advances and challenges in gene delivery mediated by polyester-based nanoparticles, International Journal of Nanomedicine, 16: 5981-6002.

https://doi.org/10.2147/IJN.S321329

Riabinina O., Quinn M., and Whitehead J., 2022, Genetic toolbox approaches in mosquitoes, Cold Spring Harbor protocols.

https://doi.org/10.1101/pdb.top107691

Rozen-Gagnon K., Yi S., Jacobson E., Novack S., and Rice C., 2020, A selectable, plasmid-based system to generate CRISPR/Cas9 gene edited and knock-in mosquito cell lines, Scientific Reports, 11: 736.

https://doi.org/10.1038/s41598-020-80436-5

Sanchez C., Wu S., Bennett J., and Marshall J., 2019, MGDrivE: a modular simulation framework for the spread of gene drives through spatially explicit mosquito populations, Methods in Ecology and Evolution, 11: 229-239.

https://doi.org/10.1111/2041-210X.13318

Schairer C., Triplett C., Akbari O., and Bloss C., 2022, California residents’ perceptions of gene drive systems to control mosquito-borne disease, Frontiers in Bioengineering and Biotechnology, 10: 848707.

https://doi.org/10.3389/fbioe.2022.848707

Tay A., and Melosh N., 2019, Transfection with nanostructure electro-injection is minimally perturbative, Advanced Therapeutics, 2(12): 1900133.

https://doi.org/10.1002/adtp.201900133

Terradas G., Macias V., Peterson H., McKeand S., Krawczyk G., and Rasgon J., 2023, The development and expansion of in vivo germline editing technologies in arthropods: Receptor-Mediated Ovary Transduction of Cargo (ReMOT Control) and beyond, Integrative and Comparative Biology, 63(6): 1550-1563.

https://doi.org/10.1093/icb/icad123

Wang G., Gamez S., Raban R., Marshall J., Alphey L., Li M., Rasgon J., and Akbari O., 2021, Combating mosquito-borne diseases using genetic control technologies, Nature Communications, 12: 4388.

https://doi.org/10.1038/s41467-021-24654-z

Wang J., and Doudna J., 2023, CRISPR technology: a decade of genome editing is only the beginning, Science, 379: eadd8643.

https://doi.org/10.1126/science.add8643

Wang Y., He X., Qiao L., Yu Z., Chen B., and He Z., 2022, CRISPR/Cas9 mediates efficient site-specific mutagenesis of the odorant receptor co-receptor (Orco) in the malaria vector Anopheles sinensis, Pest Management Science, 78(8): 3294-3304.

https://doi.org/10.1002/ps.6954

Weaver S., Charlier C., Vasilakis N., and Lecuit M., 2018, Zika, Chikungunya, and other emerging vector-borne viral diseases, Annual Review of Medicine, 69: 395-408.

https://doi.org/10.1146/annurev-med-050715-105122

Whiteman A., Loaiza J., Yee D., Poh K., Watkins A., Lucas K., Rapp T., Kline L., Ahmed A., Chen S., Delmelle E., and Oguzie J., 2020, Do socioeconomic factors drive Aedes mosquito vectors and their arboviral diseases? A systematic review of dengue, chikungunya, yellow fever, and Zika Virus, One Health, 11: 100188.

https://doi.org/10.1016/j.onehlt.2020.100188

Wilbie D., Walther J., and Mastrobattista E., 2019, Delivery aspects of CRISPR/Cas for in vivo genome editing. Accounts of Chemical Research, 52: 1555-1564.

https://doi.org/10.1021/acs.accounts.9b00106